Objectives: The main objective of this study was to determine relative levels of mtDNA copy number and hepatic FGF21 expression in a cohort of Iranian NAFLD patients and evaluate the possible relationship. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.